Cite
Clearance of Lormetazepam, Midazolam, and Their Conjugated Metabolites by Continuous Venovenous Hemofiltration During Prolonged Sedation in Critically Ill Patients With COVID-19-Associated Acute Respiratory Distress Syndrome
MLA
Shudofsky, K. N., et al. “Clearance of Lormetazepam, Midazolam, and Their Conjugated Metabolites by Continuous Venovenous Hemofiltration During Prolonged Sedation in Critically Ill Patients With COVID-19-Associated Acute Respiratory Distress Syndrome.” Journal of Clinical Pharmacology Vol.62 (2022) Nr.4 p.568-570 [ISSN 1552-4604], 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1363325128&authtype=sso&custid=ns315887.
APA
Shudofsky, K. N., Janssen, P. K. C., Foudraine, N., & le Noble, J. L. M. L. (2022). Clearance of Lormetazepam, Midazolam, and Their Conjugated Metabolites by Continuous Venovenous Hemofiltration During Prolonged Sedation in Critically Ill Patients With COVID-19-Associated Acute Respiratory Distress Syndrome. Journal of Clinical Pharmacology Vol.62 (2022) Nr.4 p.568-570 [ISSN 1552-4604].
Chicago
Shudofsky, K.N., P.K.C. Janssen, N. Foudraine, and J.L.M.L. le Noble. 2022. “Clearance of Lormetazepam, Midazolam, and Their Conjugated Metabolites by Continuous Venovenous Hemofiltration During Prolonged Sedation in Critically Ill Patients With COVID-19-Associated Acute Respiratory Distress Syndrome.” Journal of Clinical Pharmacology Vol.62 (2022) Nr.4 p.568-570 [ISSN 1552-4604]. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1363325128&authtype=sso&custid=ns315887.